Ligand Pharmaceuticals' GAAP net income for 2021 was $57.586 million, compared to a loss of $2.985 million in the previous year. Revenue increased 48.7% to $277.133 million from $186.419 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept